GeoPharma, Inc.

(NASDAQ:GORX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 524 524 735 735
Cash At End Of Period 1,361 2,004 524 400
Net Change In Cash And Cash Equivalents 837 1,480 -211 -335
Effect Of Exchange Rate Changes
Net Income Or Loss -6,367 -2,616 -7,017 -4,317
Cash From Operating Activities
Depreciation Expenses 1,393 668 1,866 1,306
Amortization Expenses 674 306 957 687
Amortization Of Intangibles Expenses
Deferred Income Taxes -1 -1 77 -2,338
Operating Gains Or Losses -1,618 -2,511
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables 3,065 1,170 2,278 3,779
Increase Or Decrease In Inventories 471 360 183 -1,071
Increase Or Decrease In Prepaid Expenses 725 285 367 265
Increase Or Decrease In Other Current Assets 725 285 367 265
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities -2,338 -2,218 2,821 1,035
Increase Or Decrease In Other Working Capital 1,380 1,006 -891 -295
Other Non Cash Items -134 37 321 94
Net Cash From Continuing Operations 323 -735 -2 -243
Net Cash From Discontinued Operations -2,427 -1,737 -1,548 -1,096
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -2,036 -1,667 -3,574 -3,587
Acquisitions 1,290 -2,238
Purchase Of Long Term Investments -370 -645
Purchase Of Short Term Investments -7,007 -7,007
Other Investing Changes Net 13 -198 -4,413 10
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -2,394 -1,865 -12,495 -12,460
Cash From Financing Activities
Issuance Of Debt 929 8 12,514 2,504
Issuance Of Capital Stock -395 -2,776 -2,073
Repayment Of Debt -25
Repurchase Of Capital Stock
Payment Of Cash Dividends 115 -126 -1,172 -1,211
Net Other Financing Charges 115 -126 -1,172 -1,211
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 5,658 5,081 13,831 13,221